Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy VolunteerProstate CancerHead and Neck CancerEsophageal CancerGenitourinary CancerSarcomaBreast CancerColon CancerGastrointestinal CancerSolid Tumor CancerLung CancerSkin CancerMelanoma
Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Roche Sequencing Solutions

INDUSTRY

collaborator

The Foundation for Barnes-Jewish Hospital

OTHER

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Radiological Society of North America

OTHER

collaborator

Skandalaris

UNKNOWN

collaborator

The V Foundation for Cancer Research

OTHER

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Washington University School of Medicine

OTHER